A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus
Clinical trial NCT06056024 · COMPLETED
Trial details
- NCT number
- NCT06056024
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2025-12-17
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.